<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="UTF-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <title>Nalamaree</title>
        <script src="/inject.js"></script>
        <link rel="stylesheet" href="/dis.css">
    </head>
<body>
    <!-- Header Section -->
  
    <section class="search-section">
        <script src="/search.js"></script>
        <input type="text" id="searchInput" placeholder="Search Disease" class="search-bar">
        <button class="search-btn" onclick="searchDisease()">Search</button>
    </section>

    <!-- Main Content Section for Pompe Disease -->
    <main class="container mt-5">
        <div class="row justify-content-center">
            <div class="col-lg-10 article-box shadow-sm p-4 rounded">
                <!-- Header Section -->
                <div class="article-header position-relative text-center">
                    <img src="/files/1673625705.jpg" alt="Pompe Disease" class="img-fluid w-100 rounded article-banner">
                </div>

                <!-- Content Section -->
                <div class="article-content mt-4">
                    <p class="text-muted">Published: 25 April 2024</p>

                    <section class="mb-5">
                        <h3 class="text-primary section-heading">Pompe Disease</h3>
                        <p>POMPE disease, also known as acid maltase deficiency or glycogen storage disease type II, is a rare and often fatal genetic disorder that affects the body's ability to break down glycogen, resulting in the buildup of glycogen in cells. It is caused by mutations in the GAA gene, leading to a deficiency of the enzyme acid alpha-glucosidase (GAA), which is responsible for breaking down glycogen.</p>
                    </section>

                    <section class="mb-5">
                        <h3 class="text-secondary">Causes</h3>
                        <p>POMPE disease is caused by mutations in the GAA gene, which provides instructions for making the enzyme acid alpha-glucosidase (GAA). This enzyme is responsible for breaking down glycogen, a complex sugar molecule, into glucose within lysosomes (cellular structures responsible for waste management).</p>
                        <p>When there are mutations in the GAA gene, the enzyme is either produced in insufficient quantities or is dysfunctional. As a result, glycogen accumulates within the cells, particularly in muscles, including heart and skeletal muscles. This accumulation impairs the function of these muscles, leading to the symptoms associated with Pompe disease.</p>
                        <p>Pompe disease is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. Individuals who inherit only one mutated copy of the gene are carriers of the disease but typically do not show symptoms themselves.</p>
                        <p>It's important to note that Pompe disease is considered a rare genetic disorder, and the specific mutations in the GAA gene can vary among affected individuals, leading to differences in the severity and onset of symptoms.</p>
                    </section>

                    <section class="mb-5">
                        <h3 class="text-secondary">Symptoms</h3>
                        <p>The symptoms of Pompe disease can vary depending on the type of the condition. In the infantile form, symptoms typically appear within the first few months of life and may include:</p>
                        <ul>
                            <li>Muscle weakness, particularly in the legs and the trunk</li>
                            <li>Enlarged heart (cardiomegaly)</li>
                            <li>Breathing difficulties</li>
                            <li>Poor muscle tone</li>
                            <li>Failure to thrive</li>
                        </ul>
                        <p>In the late-onset form, symptoms can emerge in childhood, adolescence, or adulthood, and may include:</p>
                        <ul>
                            <li>Progressive muscle weakness, especially in the legs and the trunk</li>
                            <li>Breathing difficulties, particularly during exertion or while lying down</li>
                            <li>Enlarged heart</li>
                            <li>Poor muscle tone and motor skills</li>
                            <li>Fatigue</li>
                            <li>Respiratory infections</li>
                        </ul>
                    </section>

                    <section class="mb-5">
                        <h3 class="text-secondary">Treatment: Modern Medicine</h3>
                        <ul>
                            <li><b>Enzyme Replacement Therapy (ERT):</b> This is the main treatment for Pompe disease and involves intravenous infusions of the enzyme alglucosidase alfa (brand name: Myozyme or Lumizyme). ERT can help reduce the buildup of glycogen in cells, improve muscle function, and prolong survival, especially in the infantile form of the disease.</li>
                        </ul>
                    </section>

                    <section class="mb-5">
                        <h3 class="text-secondary">Treatment: Traditional Medicine</h3>
                        <ul>
                            <li><b>Respiratory Support:</b> Since respiratory muscles can be weak in individuals with Pompe disease, various forms of respiratory support may be needed. This might include ventilator use or non-invasive ventilation techniques like BiPAP (Bilevel Positive Airway Pressure) during sleep or when respiratory function declines.</li>
                            <li><b>Physical and Occupational Therapy:</b> Therapy can help maintain muscle strength and range of motion, prevent contractures (tightening of muscles or tendons which restricts movement), and improve daily functioning.</li>
                            <li><b>Dietary Management:</b> Some individuals may require a specialized diet to address nutritional needs, especially if swallowing difficulties arise.</li>
                            <li><b>Orthopedic Interventions:</b> Surgical or non-surgical interventions may be necessary for skeletal abnormalities such as scoliosis or hip dislocation.</li>
                            <li><b>Cardiac Care:</b> Since heart muscles can be affected, especially in the infantile form, regular cardiac evaluations and management are essential. This may include medications to manage heart function or less commonly, cardiac surgery.</li>
                            <li><b>Supportive Measures:</b> A variety of other supportive measures may be needed depending on the specific symptoms, including pain management, treatment for infections, and use of mobility aids.</li>
                            <li><b>Genetic Counseling:</b> Since Pompe disease is genetic, genetic counseling can provide information on the risk of passing the disease to offspring.</li>
                        </ul>
                    </section>

                    <section class="mb-5">
                        <h3 class="text-secondary">Caution</h3>
                        <ul>
                            <li><b>Enzyme Replacement Therapy (ERT):</b> While ERT has been shown to be effective in many cases, it is not a cure, and some individuals may not respond well to treatment.</li>
                            <li><b>Breathing Issues:</b> Be cautious of breathing difficulties that may arise due to weak respiratory muscles. Ventilator support may be required in some cases.</li>
                            <li><b>Orthopedic Problems:</b> Skeletal abnormalities such as scoliosis or hip dislocation may worsen over time and require surgical interventions.</li>
                        </ul>
                    </section>

                    <section class="mb-5">
                        <h3 class="text-secondary">Conclusion</h3>
                        <p>Pompe disease is a serious and rare genetic disorder that can significantly impact an individual's life, but with early diagnosis and appropriate treatment, particularly Enzyme Replacement Therapy, individuals can experience improvements in symptoms and quality of life. Ongoing medical management, including respiratory support, therapy, and genetic counseling, is crucial for managing this condition.</p>
                    </section>

                </div> <!-- End of article-content -->
            </div> <!-- End of col-lg-10 -->
        </div> <!-- End of row -->
    </main>

    <!-- Footer Section -->
</body>
</html>
